Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 4 (2018) Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment Abstract  similar documents
Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova
"... in the acute stage of STEMI, as well as the role of the implantable cardioverter-defibrillator in primary ..."
 
Vol 6, No 6 (2010) THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS Abstract  similar documents
Yu. A. Bunin
"... of the cardioverter-defibrillators efficacy in these patients are presented. It is shown that the use of emcardioverter/em ..."
 
Vol 7, No 2 (2011) SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY Abstract  similar documents
E. V. Filippov, S. S. Yakushin
"... . High efficacy SCD emprevention/em with implanted emcardioverter/em-emdefibrillators/em is shown. However ..."
 
Vol 15, No 4 (2019) Pathogenic Variant Rs1471414348of the TTN Gene in the Patient with Familial Left Venticular Noncompaction Cardiomyopathy Abstract  similar documents
O. V. Kulikova, A. N. Meshkov, R. P. Myasnikov, A. V. Kiseleva, S. N. Koretsky, A. A. Zharikova, M. S. Kharlap, E. A. Mershina, V. E. Sinitsyn, O. P. Skirko, I. A. Efimova, M. S. Pokrovskaya, S. A. Boytsov, O. M. Drapkina
"... , and a emcardioverter/em emdefibrillator/em was implanted for the primary emprevention/em of sudden cardiac death. Given ..."
 
Vol 8, No 4 (2012) UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION Abstract  similar documents
E. A. Protasova, N. V. Furman, O. V. Reshet'ko
"... and clinical studies show that the use of these drugs may be useful for AF primary emprevention/em in certain ..."
 
Vol 14, No 3 (2018) CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... emprevention/em of arrhythmia in hypertensive patients.  ..."
 
Vol 14, No 4 (2018) Differences in the Incidence of Major Risk Factors in Patients with Ischemic or Hemorrhagic Stroke in the Siberian Population Abstract  similar documents
S. Yu. Nikulina, A. A. Chernova, D. A. Nikulin, V. A. Shulman, S. V. Prokopenko, I. M. Platunova, O. V. Marilovceva, I. I. Lebedeva, A. A. Semenchukov, D. A. Yakovleva, V. N. Maksimov, A. V. Kuskaeva
"... emprevention/em of this disease remains relevant. There are modifiable and non-modifiable RF. Aim. To study ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
 
Vol 1, No 2 (2005) STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY Abstract  similar documents
Y. A. Karpov
"... of statines efficiency in emprevention/em of ischemic heart disease (IHD), are analyzed. Decrease in risks ..."
 
Vol 9, No 4 (2013) ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES Abstract  similar documents
E. N. Dankovtseva
"... Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary emprevention/em ..."
 
Vol 14, No 6 (2018) Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues Abstract  PDF (Eng)  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
"... attention is paid to the use of statins in the primary emprevention/em of cardiovascular complications ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The definition of primary emprevention/em of cardiovascular diseases is presented. Statins preventive ..."
 
Vol 2, No 2 (2006) STROKE PREVENTION IN HYPERTENSIVE PATIENTS Abstract  similar documents
S. Y. Martsevich, V. A. Egorov
"... of primary and secondary stroke emprevention/em are discussed. ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... Stroke secondary emprevention/em in internist practice is discussed in accordance with up to date ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
"... The evidence base of statin therapy in primary and secondary emprevention/em of ischemic stroke ..."
 
Vol 10, No 2 (2014) PUBLIC HEALTH: FOCUS ON THE PREVENTION Abstract  similar documents
P. Puska, N. V. Dolgushina
 
Vol 8, No 2 (2012) ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS Abstract  similar documents
A. V. Govorin, A. P. Filev
"... of acetylsalicylic acid (ASA) in primary and secondary emprevention/em of atherothrombotic events. Studies on the safety ..."
 
Vol 6, No 4 (2010) ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS Abstract  similar documents
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov
 
Vol 10, No 2 (2014) SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT Abstract  similar documents
E. A. Drozdova
"... of the management of patients with stroke due to non-valvular atrial fibrillation and secondary stroke emprevention/em ..."
 
Vol 11, No 1 (2015) VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT Abstract  PDF (Eng)  similar documents
R. G. Oganov
"... on the cardiovascular risk, general causes and approaches to the emprevention/em and treatment of vascular comorbidity ..."
 
Vol 8, No 4 (2012) ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? Abstract  similar documents
I. V. Zhirov
"... to the cancer emprevention/em. This ASA indication should be confirmed in additional studies. ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... emprevention/em. Material and methods. This study based on the questionnaire survey of 544 patients from three ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... clinical trial dabigatran 150 mg b.i.d was more effective than warfarin in emprevention/em of ischemic stroke ..."
 
Vol 5, No 6 (2009) STATIN GENERICS: EFFICACY AND SAFETY RATIO Abstract  similar documents
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova
"... Statin usage for primary and secondary emprevention/em of cardiovascular diseases is focused. Rational ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... for primary and secondary emprevention/em of cardiovascular diseases. 276 questionnaires filled out by 185 ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... emprevention/em of cardiovascular diseases in patients with a history of myocardial infarction in ambulatory ..."
 
Vol 13, No 2 (2017) POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER Abstract  similar documents
Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina
"... Aim. To study the efficacy of ivabradine in the emprevention/em of cardiotoxic effects due ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... Aim. To study secondary emprevention/em of cardiovascular diseases among patients of different age ..."
 
Vol 9, No 4 (2013) COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS Abstract  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
 
Vol 8, No 6 (2012) SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE Abstract  similar documents
E. V. Filippov, S. S. Yakushin
"... The most pressing issues of the secondary drug emprevention/em of the most common cardiovascular ..."
 
Vol 9, No 5 (2013) PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko
"... dabigatran etexilate, in the stroke emprevention/em in patients with atrial fibrillation are considered. Factors ..."
 
Vol 10, No 6 (2014) PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION Abstract  similar documents
N. V. Mikheeva, O. V. Reshetko, N. V. Furman
 
Vol 16, No 3 (2020) Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics? Abstract  similar documents
S. G. Kanorskii
"... , and amputation. Secondary emprevention/em in these high-risk patients should include control of modifiable risk ..."
 
Vol 9, No 3 (2013) NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES Abstract  similar documents
M. G. Gambaryan
"... of cardiorespiratory diseases. Smoking cessation is the most cost-effective measure for emprevention/em of cardiovascular ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... the efficacy of multifactor primary emprevention/em. Material and methods. The analysis was based on the results ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
 
Vol 1, No 3 (2005) EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE Abstract  similar documents
G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. Manger Cats, K. Orth-Gomer, J. Perk, K. Pyorala, J. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen, D. Wood
"... European guidelines on cardiovascular disease emprevention/em in clinical practice. ..."
 
Vol 16, No 2 (2020) Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis “Amyloidosis” as a Manifestation of Danon Disease in a Woman Abstract  PDF (Eng)  similar documents
O. V. Blagova, E. A. Kogan, V. P. Sedov, Yu. A. Lutokhina, A. V. Nedostup, A. V. Ott, L. M. Dashinemaeva, E. V. Zaklyazminskaya
"... , emcardioverter/em-emdefibrillator/em was implanted. The analysis of literature data on the frequency ..."
 
Vol 10, No 2 (2014) PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM Abstract  PDF (Eng)  similar documents
A. M. Kalinina, A. V. Kontsevaya
"... -aged men during 15-year follow-up; to evaluate economic efficiency of primary medical emprevention/em ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... the benefits of rosuvastatin in the emprevention/em and treatment of cardiovascular diseases are presented. ..."
 
Vol 7, No 6 (2011) EXPERIENCE OF «SCHOOL OF HEALTH» AND A ROLE OF THE GENERAL PRACTITIONER IN THE STRUGGLE WITH RISK FACTORS OF ISCHEMIC HEART DISEASE Abstract  similar documents
N. M. Nurillaeva, A. G. Gadaev
 
Vol 11, No 1 (2015) CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina
"... of recurrent strokes indicates an underactive secondary emprevention/em. ..."
 
Vol 11, No 1 (2015) THE WAY OF ASSESSING THE ADHERENCE TO MODERN DRUG THERAPY CLINICAL GUIDELINES AIMED AT REDUCING THE RISK OF RECURRENT STROKE (ACCORDING TO THE LIS-2 REGISTER) Abstract  similar documents
A. Yu. Suvorov, S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev, M. L. Ginzburg, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina
"... Aim. To develop a method for the assessment of quality of medical emprevention/em of recurrent stroke ..."
 
Vol 11, No 3 (2015) EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER) Abstract  similar documents
A. Yu. Suvorov, S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev, M. L. Ginzburg, A. V. Akimova, E. V. Daniels, A. V. Fokina, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov
"... for the emprevention/em of recurrent stroke along with the emprevention/em of recurrent ischemic attacks index (PRIA index ..."
 
Vol 14, No 6 (2018) Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) Abstract  PDF (Eng)  similar documents
L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... and emprevention/em is discussed. Some large randomized clinical trials are analyzed. Physical and chemical properties ..."
 
Vol 6, No 5 (2010) THE INFECTIVE ENDOCARDITIS (PREVENTION, DIAGNOSIS CRITERIA AND TREATMENT): KEY POINTS 2010 Abstract  similar documents
A. A. Demin
"... Key positions of Guidelines on the emprevention/em, diagnosis, and treatment of infective endocarditis ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... to patients’ death. The emprevention/em of VTE events suggests the prescription of low molecular weight heparin ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
 
Vol 10, No 6 (2014) CONFERENCE “GENETIC TESTING AS A SOCIAL RESPONSIBILITY OF CITIZENS AND A DISABILITY PREVENTION” Abstract  similar documents
 
Vol 10, No 4 (2014) OPTIMAL PREVENTION OF HOSPITAL VENOUS THROMBOEMBOLISM WITH THE HELP OF MEDICAL INFORMATION SYSTEM Abstract  similar documents
G. I. Nazarenko, S. A. Payushk, V. A. Otdelenov, E. B. Kleymenova, L. P. Yashina, D. A. Sychev
"... of clinical guidelines for the emprevention/em of venous thromboembolic complications there is a gap between ..."
 
Vol 7, No 2 (2011) SUDDEN CARDIAC DEATH: ETIOLOGICY IN PATIENTS OF DIFFERENT AGES, RISK FACTORS AND PREVENTION Abstract  similar documents
O. V. Gaisenok
"... in different ages, risk factors and emprevention/em. ..."
 
Vol 16, No 3 (2020) The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... ) in the emprevention/em of heart rhythm disorders and the emprevention/em of sudden cardiac death. In experimental studies ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... of myocardial perfusion. Despite the ongoing work on primary emprevention/em, it is advisable to recommend sending ..."
 
Vol 7, No 4 (2011) GENDER DIFFERENCES IN THE EFFICACY OF RISK FACTORS CORRECTION AND TREATMENT COMPLIANCE IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. Y. Efanov, D. F. Nizamova, E. F. Dorodneva, I. V. Medvedev, S. V. Shalaev
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... emprevention/em of cardiovascular diseases in patients with stable angina on the level of out-patient specialized ..."
 
Vol 5, No 4 (2009) GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY Abstract  similar documents
A. L. Komarov
 
Vol 15, No 2 (2019) Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov
 
Vol 16, No 1 (2020) Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease Abstract  similar documents
A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko
"... , alirocumab, on lipid levels in patients who receive secondary emprevention/em of cardiovascular diseases (CVD ..."
 
Vol 16, No 2 (2020) Clinical profile and drug therapy of outpatients with arterial hypertension Abstract  similar documents
N. V. Izmozherova, A. A. Popov, V. M. Bakhtin, M. A. Shambatov
 
Vol 16, No 3 (2020) On the Quality of Medical Examination: Diagnostic Significance of the Survey Method for Detecting the Probability of Cardio-Cerebral Symptoms Abstract  similar documents
A. M. Kalinina, K. A. Antonov, B. E. Gornyi, I. I. Dubovoj, O. M. Drapkina
"... the point of view of timely emprevention/em. Neurological symptoms according to the automated survey were ..."
 
Vol 16, No 3 (2020) A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study Abstract  similar documents
N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey
 
Vol 4, No 3 (2008) EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE . Abstract  similar documents
I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reimer, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano
"... Society of Cardiology (ESC), в состав которого входят European Association for Cardiovascular emPrevention/em ..."
 
Vol 4, No 4 (2008) EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE Abstract  similar documents
I. Graham, D. Ata, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backe, Sh. Ebrahim, B. Gjelsvik, Ch. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reime, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano
"... emпрофилактике/em сердечно-сосудистых заболеваний в клинической практике. Приглашенные эксперты: Edmond Walma ..."
 
Vol 6, No 6 (2010) GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) Abstract  similar documents
Gilbert Habib, Bruno Hoen, Pilar Tornos, Franck Thuny, Bernard Prendergast, Isidre Vilacosta, Philippe Moreillon, Manuel de Jesus Antunes, Ulf Thilen, John Lekakis, Maria Lengyel, Ludwig Muller, Christoph K. Naber, Petros Nihoyannopoulos, Anton Moritz, Jose Luis Zamorano, M. O. Evseev
"... Guidelines on the emprevention/em, diagnosis, and treatment of infective endocarditis (new version 2009). ..."
 
Vol 6, No 5 (2010) GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) Abstract  similar documents
Gilbert Habib, Bruno Hoen, Pilar Tornos, Franck Thuny, Bernard Prendergast, Isidre Vilacosta, Philippe Moreillon, Manuel de Jesus Antunes, Ulf Thilen, John Lekakis, Maria Lengyel, Ludwig Muller, Christoph K. Naber, Petros Nihoyannopoulos, Anton Moritz, Jose Luis Zamorano, M. O. Evseev
"... Guidelines on the emprevention/em, diagnosis, and treatment of infective endocarditis (new version 2009). ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... For emprevention/em of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... to recommend discussed cardiovascular drugs for emprevention/em of osteoporosis and fractures, as well ..."
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
"... Acetylsalicylic acid (ASA) use in the primary and secondary emprevention/em of cardiovascular diseases ..."
 
Vol 2, No 2 (2006) PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING Abstract  similar documents
N. S. Oganisyan, N. A. Dmitrieva, A. M. Kochetkov, S. Y. Martsevich
"... blood pressure level below 140/90 mm Hg as target level of secondary emprevention/em. Mainly antihypertensive ..."
 
Vol 2, No 3 (2006) APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY Abstract  similar documents
S. V. Nedogoda
 
Vol 4, No 3 (2008) COMMENTS ON EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE Abstract  similar documents
S. A. Shalnova
 
Vol 15, No 5 (2019) Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko
"... as a drug that has a favorable efficacy profile for primary and secondary stroke emprevention/em. Rivaroxaban ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION Abstract  similar documents
Ju. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolaev
"... outcomes, emprevention/em of complications and long-term prognosis are ignored. Authors concluded ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... for the treatment and emprevention/em of cardiovascular diseases caused by atherosclerosis. The milestones of lipid ..."
 
Vol 10, No 6 (2014) NEXIUM. PREVENTION OF GASTRODUODENAL ULCER ASSOCIATED WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS Abstract  similar documents
"... Nexium. emPrevention/em of gastroduodenal ulcer associated with nonsteroidal anti-inflammatory drugs. ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... Aim. To assess the cost-effectiveness of apixaban in the treatment and secondary emprevention/em ..."
 
Vol 1, No 3 (2005) EDITORIAL COMMENTS ON “EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE” Abstract  similar documents
"... Editorial comments on “european guidelines on cardiovascular disease emprevention/em in clinical ..."
 
Vol 15, No 2 (2019) Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL) Abstract  similar documents
I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov, V. A. Kokorin
 
Vol 13, No 4 (2017) PREVENTION AND EVIDENCE-BASED MEDICINE ARE THE MAIN ASSISTANTS OF THE PHYSICIAN. INTERVIEW WITH PROFESSOR S.YU. MARTSEVICH Abstract  similar documents
N. V. Dolgushina
 
Vol 6, No 5 (2010) FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. O. Shevchenko, O. P. Shevchenko
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... and regional programs for the emprevention/em of thromboembolic complications in this group of patients. ..."
 
Vol 8, No 1 (2012) PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE Abstract  similar documents
M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova
"... to emprevention/em of type 2 diabetes mellitus (DM). Data of international clinical trials shows that early GMD ..."
 
Vol 7, No 1 (2011) THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS Abstract  similar documents
O. V. Gaisenok
"... Current issues of atherothrombosis emprevention/em and treatment optimization with antiplatelet therapy ..."
 
Vol 7, No 1 (2011) USE OF N-3 POLYUNSATURATED FATTY ACIDS 90% (OMACOR) FOR THERAPY AND PREVENTION OF CARDIO-VASCULAR DISEASES  similar documents
 
Vol 2, No 3 (2006) NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION Abstract  similar documents
A. I. Martinov, V. L. Chomenko
"... provided. It is suggested to use Omega-3 PUFAs (OMAKOR) for secondary emprevention/em of ischemic heart disease ..."
 
Vol 4, No 3 (2008) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION Abstract  similar documents
A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... Measures for the emprevention/em of cardiovascular diseases (CVD) are more effective ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... Council on the significance of testing of platelet functional activity in the emprevention/em of cardiovascular ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... Aim. To evaluate the efficacy of atorvastatin therapy in emprevention/em of atrial fibrillation (AF ..."
 
Vol 6, No 4 (2010) ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov
"... diseases emprevention/em at a workplace. Material and methods. The complex of activities including preventive ..."
 
Vol 7, No 4 (2011) METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE Abstract  similar documents
M. S. Berezhnova
"... is presented. Particular attention is paid to the recommendations for treatment and emprevention/em ..."
 
Vol 6, No 4 (2010) RUSSIAN EXPERTS’ CONSENSUS ON METABOLIC SYNDROME PROBLEM IN THE RUSSIAN FEDERATION: DEFENITION, DIAGNOSIS CRITERIA, PRIMARY PREVENTION AND TREATMENT Abstract  similar documents
N. M. Achmegdanov, S. A. Butrusova, I. I. Dedov, L. A. Zvenigorodskaya, O. A. Kislyak, O. A. Koshelskaya, I. V. Kuznecova, V. V. Kuharchuk, A. Yu. Litvin, I. V. Medvedeva, A. M. Mkrtumyan, V. B. Mychka, D. V. Nebieridze, S. V. Nedogoda, R. G. Oganov, M. Yu. Ogarkov, N. B. Perepech, V. I. Podzolkov, V. P. Smetnik, A. V. Susekov, V. N. Titov, T. V. Tyurina, A. N. Fursov, V. N. Hirmanov, I. E. Chazova, I. I. Chukaeva, M. V. Shestakova, A. T. Shubina
"... , Diagnosis Criteria, Primary emPrevention/em and Treatment. ..."
 
Vol 6, No 6 (2010) X RUSSIAN SCIENTIFIC CONFERENCE WITH INTERNATIONAL PARTICIPATION “REHABILITATION AND SECONDARY PREVENTION IN CARDIOLOGY”, MAY 18-19, 2011, MOSCOW Abstract  similar documents
"... emPrevention/em in Cardiology”, May 18-19, 2011, Moscow. ..."
 
Vol 7, No 6 (2011) DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER Abstract  similar documents
I. S. Yavelov
"... Application of dabigatran etexilate for emprevention/em of cardioembolic complications in nonvalvular ..."
 
Vol 14, No 3 (2018) HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE Abstract  similar documents
O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta
"... . The issues of lipid-lowering therapy with statins in the aspect of stroke emprevention/em are discussed ..."
 
Vol 5, No 1 (2009) UP TO DATE INFORMATION FOR LEADING CARDIOLOGISTS AND THERAPEUTISTS ABOUT LATEST PREVENTION AND THERAPY METHODS REDUCES GROWTH RATE OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. Aleeva
"... Up to date information for leading cardiologists and therapeutists about latest emprevention/em ..."
 
Vol 5, No 4 (2009) PREVENTION OF LEFT VENTRICLE SYSTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AFTER CARDIAC REVASCULARIZATION Abstract  similar documents
A. L. Alyavi, B. A. Alyavi, M. L. Kenzhaev, S. R. Kenzhaev
 
Vol 2, No 1 (2006) THE USE OF A NEW APPROACH TO PREVENTION AND THERAPY OF ACUTE ARTERIAL HYPERTENSION WITH COMPLEX OF WELL-KNOWN DRUGS WITH VEGETABLE GLYCOSIDES (EXPERIMENTAL STUDY) Abstract  similar documents
T. G. Tolstikova, I. V. Sorokina, A. O. Brisgalov, M. P. Dolgich, G. I. Lifshitz, M. V. Chvostov
"... with this in N. NC can be used for emprevention/em and therapy of acute arterial hypertension. ..."
 
1 - 100 of 285 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)